Patents by Inventor David Whitman

David Whitman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Surface promoted Michael cure compositions
    Publication number: 20060078742
    Abstract: A curable composition comprising: at least one multi-functional Michael donor, at least one multi-functional Michael acceptor, and at least one reaction promoter, wherein the at least one reaction promoter is applied to at least one substrate or is included in one or more compositions applied to at least one substrate.
    Type: Application
    Filed: October 7, 2005
    Publication date: April 13, 2006
    Inventors: Thomas Kauffman, David Whitman, Michael Zajackowski
  • Biomass based Michael addition compositions
    Publication number: 20060069234
    Abstract: Functional mixtures and polymer compositions are provided, each comprising at least one multi-functional Michael acceptor, at least one multi-functional Michael donor, in which at least 20% of either the donor or acceptor or a combination of the donor and acceptor is derived from bio-based materials and at least one catalyst.
    Type: Application
    Filed: September 22, 2005
    Publication date: March 30, 2006
    Inventors: Thomas Kauffman, David Whitman, Michael Zajaczkowski, David Vietti
  • Michael addition compositions
    Publication number: 20050245721
    Abstract: A functional mixture is provided that comprises at least one multi-functional Michael acceptor, at least one multi-functional Michael donor, and at least one weakly basic catalyst.
    Type: Application
    Filed: May 2, 2005
    Publication date: November 3, 2005
    Inventors: Ronald Beckley, Thomas Kauffman, Michael Zajaczkowski, David Whitman
  • Fibrinogen receptor antagonists
    Patent number: 5264420
    Abstract: Fibrinogen receptor antagonists of the formula: ##STR1## are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.
    Type: Grant
    Filed: March 25, 1992
    Date of Patent: November 23, 1993
    Assignee: Merck & Co., Inc.
    Inventors: Mark E. Duggan, Melissa S. Egbertson, Nathan Ihle, George D. Hartman, Laura M. Turchi, David Whitman